Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology ...
Individuals whose graduate work has been in the field of dental medicine may apply for advanced standing through the Oral-Maxillofacial Surgery (OMFS)/MD Program. Information regarding the combined ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic ...
Founded to accelerate innovation in glaucoma treatment, Glaucoma 360 is GRF's signature event and one of the vision community's most anticipated annual gatherings. The three-day program features a ...
The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur joined the FDA in 1999 and recently served as founding director of the ...
Within a thriving educational and research environment, the Department of Chemistry makes pioneering discoveries, and advances real-world applications of chemistry. We take pride in our collaborative ...
ERS 2025 covered lung cancer treatment advances like robot-assisted bronchoscopy with integrated cone-beam CT (RAB-CBCT) and ...
A 26-year FDA scientist and administrator, Pazdur has headed the agency's Oncology Center of Excellence since its creation in 2017, coordinating expedited review of drugs and devices. During his ...
The disciplines of pharmacology and physiology touch on virtually every field of the biomedical sciences, presenting endless opportunities to discover disease mechanisms and develop new treatments.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
The age of silos is over. We have moved towards synergized working across biotechnology, medical research, agriculture, and data-driven science,” Dr. Singh said.